Liraglutide, offered under various trade names, is a significant medication initially intended for treating type 2 diabetes. However, its ability to promote substantial fat decrease has led to its expanded use, with some formulations now explicitly indicated for obesity. This administered medication works by acting like a natural hormone, the GLP-1